An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)
ConclusionThe results of efficacy and safety of HCQ in COVID-19, as obtained from the clinical studies, are not satisfactory, although many of these studies had major methodological limitations. Stronger evidence from well-designed robust randomized clinical trials is required before conclusively determining the role of HCQ in the treatment of COVID-19. Clinical prudence is required in advocating HCQ as a therapeutic armamentarium in COVID-19.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Azithromycin | Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Hydroxychloroquine | Pandemics | Study | Virology | Zithromax